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Abstract
The military veteran population has received national attention for the struggles some of its
members have had with posttraumatic stress disorder (PTSD). Currently, PTSD is treated within
the VA using a number of pharmacologic and/or psychotherapeutic interventions in residential
and outpatient settings. The purpose of this research project was to learn more about PTSD
treatment by conducting a program evaluation of therapies offered in a VA PTSD program. A
non-probability sample of 124 veterans who participated in a VA residential PTSD program in
the mid-western United States between 2006 and 2009 was used to determine the effectiveness
of Cognitive Processing Therapy (CPT), Prolonged Exposure Therapy (PE), and Eye Movement
Desensitization and Reprocessing Therapy (EMDR) on PTSD and depression symptoms over
time. Each therapy provided resulted in decreased symptomotology of PTSD and depression
from pre- to post-treatment, with no therapy showing greater efficacy over the others. However,
at 6- and 12-month follow-up measurements, PTSD and depression symptoms increased to
approach pre-treatment values for all therapies examined in this project. The future direction of
research, practice, and policy surrounding PTSD treatment must be further examined to
consistently provide competent, effective care to every veteran served by the VA.
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The military veteran population, having endured conflicts of war to secure the freedom of
the United States, has received national attention for the struggles some of its members have had
with posttraumatic stress disorder (PTSD). In retrospect, PTSD has been acknowledged in
military and veterans service arenas since the 1670s, when Swiss military doctors referred to it as
“nostalgia.” Since that time, other names have developed for this disorder, including
“exhaustion,” “soldier’s heart,” “the effort syndrome,” “shell shock,” “combat fatigue,” “battle
fatigue,” and “Post-Vietnam Syndrome,” before arriving at “Posttraumatic Stress Disorder” in
1980 (Vietnam Veterans of America [VVA], 2007). Today, PTSD is characterized by symptoms
of re-experiencing, hyperarousal, and avoidance to stimuli that remind one of a traumatic
event(s) he or she has experienced (e.g., military combat, rape, being witness to the violent death
of a friend or family member; Dworkin, 2003).
For those veterans who have served in Operations Enduring Freedom and Iraqi Freedom
(OEF/OIF), approximately 15% or more have developed PTSD (Shiner, 2011), compared to 30%
and 26%, respectively, of male and female Vietnam war veterans, approximately 10% of Gulf
War veterans, and 8% of veterans deployed to Somalia (Friedman, 2005). Between 1999 and
2004, the number of veterans reporting PTSD increased from 120,265 to 215, 871. During this
same time period, veterans’ compensation for suffering from PTSD as a result of their military
duties rose from 1.72 to 4.28 billion dollars (Committee on Veterans’ Compensation for PTSD,
2007; Institute of Medicine [IOM] & National Research Council, 2007).
Based on the rising cases and mental and physical health costs of PTSD (Shiner, 2011),
Congress has allotted considerable funding to the Department of Veterans Affairs (VA) and the
Department of Defense (DOD; Levin, 2011). The VA has used its portion of this funding to
research and provide the best care available to its veterans. Currently, PTSD is treated within the
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VA using a number of pharmacologic (e.g., selective serotonin reuptake inhibitors and serotoninnorepinephrine reuptake inhibitors) and/or psychotherapeutic (e.g., cognitive behavioral therapy
[CBT], brief psychodynamic psychotherapy, and family and group therapy) interventions in
residential and outpatient settings (Sharpless & Barber, 2011; National Center for PTSD
[NCPTSD], 2010). More recently, PTSD treatment programs offered by the VA have focused
on two evidence-based CBT treatments that have been shown to be very successful in treating
PTSD: Cognitive Processing Therapy (CPT) and Prolonged Exposure (PE; NCPTSD, 2010).
Studies have generally shown that CPT and PE are both effective therapies. Rauch et al.
(2009), for example, found that PE therapy significantly reduced total PTSD symptoms in
veterans (i.e., those from different conflicts and those who experienced military sexual trauma or
MST) with chronic PTSD from pre- to post-treatment. A study of veterans who completed a
PTSD treatment program in a VA residential setting supported both CPT and Eye Movement
Desensitization and Reprocessing (EMDR) as effective therapies for veterans, based on pre- and
post-treatment results of several test measures (Graca, Palmer, & Occhietti, 2012). Eye
Movement Desensitization and Reprocessing therapy has been deemed effective in the reduction
of PTSD symptoms in civilian, military, and veteran populations, with outcomes similar to those
of exposure-based therapies. The 2010 treatment guidelines for the VA and DOD also
recommended EMDR, though these same guidelines questioned the theoretical and empirical
grounding of its more unique components (Sharpless & Barber, 2011; VA/DOD, 2010). And, as
reported by Devilly, Spence, and Rapee (1998) in their study of combat veterans with PTSD, the
eye movement procedure used in EMDR is most likely not the mechanism of change in PTSD
symptoms; rather, other factors, such as the imaginal exposure process of EMDR, may be the
impetus for symptom improvement. For these reasons, studies continue to research the
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effectiveness of this therapy while it is offered in variation at some VA facilities (NCPTSD,
2010). Currently, however, CPT and PE remain the most widely disseminated therapies with the
VA (Sharpless & Barber, 2011; VA/DOD, 2010).
The knowledge base for the effectiveness of various PTSD treatments offered in VA
settings is still transforming and expanding. In fact, the IOM, at the request of the DOD, is
currently conducting a study of all PTSD treatments offered at VA and DOD facilities to
determine the best method(s) for screening, prevention, treatment, and rehabilitation of active
duty military personnel and veterans with PTSD (Levin, 2011). Current literature suggests many
veterans, especially females, present to VA Primary Health Clinics with physical complaints,
which may be the result of or include underlying mental health issues (Friedman, 2005; Shiner,
2011). Consequently, symptoms of PTSD or other mental health disorders veterans have can go
undetected by clinicians. However, changes within the VA, such as the integration of primary
care and mental health departments, has greatly improved this screening process (Sadler, Booth,
Nielson, & Doebbeling, 2000; Valente & Wight, 2007). Additional studies indicate there are
several factors which may influence veterans’ participation in and completion of PTSD
treatment, including severity of PTSD symptoms, health, family and work commitments,
motivation for change, and family involvement/social support before, during, and after treatment
(Kutter, Wolf, & McKeever, 2004; Batten et al., 2009).
These research findings show there is currently a strong evidence-based understanding of
the ways in which PTSD can be treated within the veteran population but additional research is
needed. For example, Chard, Schumm, Owens, and Cottingham (2010) suggest OEF/OIF and
Vietnam veterans respond differently to treatment and, therefore, future studies should examine
multiple variables related to when veterans served in the military. And, of the sources reviewed
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for this project, only one involved a study in which a 5-year follow-up of the treatment effects of
cognitive therapy and imaginal exposure on chronic PTSD was conducted; cognitive therapy was
found to be more effective in maintaining alleviation of PTSD symptoms (Tarrier &
Sommerfield, 2004). Future studies can expand the depth and breadth of understanding of PTSD
treatment, thereby informing clinicians about the most effective care available to veterans.
The purpose of this research project was to learn more about PTSD treatment by
conducting a program evaluation of the therapies (i.e., CPT, PE, and EMDR) offered in a VA
residential PTSD program. The progression of symptoms, as measured by test scores obtained
before, immediately after, and 6 and 12 months after completion of the PTSD program, were
examined using a secondary quantitative data analysis. Particular attention was given to how
treatment outcomes are affected by and/or correspond to the following variables: age, gender,
ethnicity, and type of treatment received in the PTSD program. This method, in turn, provided
insight into the following research question that was posed for this project: How does a PTSD
program offered through the VA affect symptoms of PTSD and depression in veterans who have
completed treatment?
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Literature Review
Subjection to traumatic events, such as abuse, combat, death, and natural disasters, can
lead one to develop symptoms of PTSD, which, as mentioned earlier, are categorized as reexperiencing, emotional numbing and avoidance, and hyperarousal. This mental health disorder
is especially pronounced in military veterans. It is common for veterans to present to VA
primary health facilities with co-morbid physical and mental health conditions. In response to
this trend, the VA currently offers an array of psychopharmacological and psychotherapeutic
treatments. However, further research of current treatment options for PTSD with different
study populations will increase the quality of care available to veterans and civilians alike.
PTSD
Etiology. A thorough explanation of PTSD provides a point of reference for
understanding the experiences of veterans, as well as military personnel and civilians, diagnosed
with this disorder. Resulting from both manmade and natural events, PTSD “…shock[s] the
psychological system and violate[s] core assumptions that life is predictable, safe and secure”
(Sharpless & Barber, 2011, p. 8). According to the VVA (2007), PTSD is an anxiety disorder
that surfaces after experiencing a very dangerous, uncontrollable, and frightening event, such as
a car wreck, sexual assault, terrorist attack, military combat, tornado, hurricane, or earthquake.
Chard et al. (2010) found OEF/OIF and Vietnam veterans differed in their likeliness to
develop PTSD, based on the type of warfare they were subjected to and the type of homecoming
they received once they returned to the United States (i.e., Vietnam veterans were treated with
disdain when they returned and most OEF/OIF veterans have been greeted by celebrations and
recognition). Additional factors that can affect the likelihood of veterans developing PTSD are
active duty pre-deployment concerns about family and life disruption, pre-deployment
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personality and trauma history, previous combat exposure, post-deployment social support and
stressors, gender, race, and military rank (Erbes & Polusny, 2009).
Diagnosis. A diagnosis of PTSD is typically made by evaluating an individual for the
presence of PTSD symptoms. The symptoms are categorized into three groups: a) reexperiencing symptoms, such as recurrent and distressing recollections of the event, recurrent
dreams of the event, or feeling that the event is happening again in the form of hallucinations or
dissociative flashbacks; b) avoidance symptoms, such as emotional numbing and making efforts
to avoid places and people that are reminders of the event; and c) hyperarousal symptoms, such
as exaggerated startle response, hypervigilance, and difficulty falling or staying asleep (Dobie et
al., 2002; American Psychiatric Association [APA], 2000). These symptoms can be: a) acute,
usually lasting one to three months after the traumatic event, b) chronic, usually lasting three or
more months after the traumatic event, and/or c) have a delayed onset, with at least a 6-month
lapse between the traumatic event and the onset of symptoms (VVA, 2007).
Research using brain imaging has revealed people suffering from PTSD exhibit similar
anomalies in brain function and structure. These include altered psychophysiological reactivity,
hormonal balance, cognitive processing, and memory function (Friedman, 2005). Van der
Kolk’s (2006) research supplements these findings. He determined “. . .that when people are
reminded of a personal trauma[,] they activate brain regions that support intense emotions, while
decreasing activity of brain structures involved in the inhibition of emotions and the translation
of experience into communicable language” (p. 2). Georgopoulos et al. (2010) supplemented
these findings through their study of neural activity and communication patterns in the brain’s
cerebral cortex. They concluded, through the use of magnetoencephalographic (MEG)
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recordings, differences in brain function can be discerned for individuals with PTSD as opposed
to those without this disorder.
In addition to emotional distress, family, marital, and social functioning are compromised
(Friedman, 2005). According to Batten et al. (2009), those who develop PTSD are more likely to
have reduced intimacy with partners, expressions of hostility, poor communication skills, a
lowered ability to resolve personal conflict, and child rearing difficulties. Solomon, DebbyAharon, Zerach, and Horesh (2011) also found that severity of PTSD symptoms tend to be
negatively correlated with marital adjustment and parental functioning.
Prevalence. Studies using national VA administrative data have revealed a consistent
rise in PTSD over time among OEF/OIF veterans, from 0.2% in 2003 to 21.8% in 2005 (Seal et
al., 2009). Additionally, 26% to 30% of Vietnam veterans, approximately 10% of Gulf War
veterans, and 8% of veterans deployed to Somalia have developed PTSD. Specifically, those
with injuries resulting from combat were and are more likely to develop PTSD (Friedman, 2005).
In comparison to the veteran population, approximately 8% of the civilian population is
affected by PTSD during its lifetime, as are 33% to 50% of numerous study samples marked by
some type of trauma (Schottenbauer, Glass, Arnkoff, Tendick, & Gray, 2008). For example,
Resnick, Kilpatrick, Dansky, Saunders, and Best (1993) found that, of those who suffered
civilian rape, approximately 32% had lifetime PTSD and about 12% had current PTSD. These
percentages were almost identical for victims of some type of sexual assault other than rape (i.e.,
31% with lifetime PTSD and 12% with current PTSD).
Females, whether in the military/veteran or civilian population, have also been correlated
with the presence of PTSD symptoms, due to vulnerabilities they face (e.g., different types of
abuse) as children and adults (Dobie et al., 2002). However, even though female veterans have
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reported higher rates of trauma exposure than the civilian population and are more likely than
male veterans to experience sexual assault while in the military, they are equally or less likely
than male veterans to meet criteria for PTSD (Zinzow, Grubaugh, Monnier, Suffoletta-Maierie,
& Frueh, 2007). Other research has revealed mixed findings regarding differences in PTSD
between male and female veterans, though female veterans have tended to show less resilience to
PTSD than their male counterparts (Kimerling, Gima, Smith, Street, & Frayne, 2007).
The tragedy from which PTSD develops can literally happen to anyone as the result of an
array of factors. However, veterans, both male and female, are at an especially high risk of
experiencing PTSD symptoms, due to combat exposure and MST. And, because these
symptoms can be very detrimental to personal, social, and occupational functioning, the VA
serves as an important resource for veterans with PTSD.
Presentation of PTSD in VA settings
Primary health care facilities. It is more common for veterans experiencing PTSD
symptoms to present to primary health clinics to seek medical, rather than mental, health care
(Friedman, 2005). According to Frayne et al. (2011), male and female OEF/OIF veterans with
PTSD who use VA facilities are more likely than veterans without a mental health diagnosis to
suffer from one or more medical illnesses, including lumbosacral spine disorders, lower
extremity joint disorders, headaches and hearing problems. Additionally, women who have
PTSD as a result of MST and/or military combat commonly seek VA Primary Health services
for physical problems (e.g., gynecological, digestive) that are related to their trauma
(Himmelfarb, Yaeger, & Mintz, 2006). Zinzow et al. (2007) have suggested VA Primary Health
clinics can benefit from expanding their mandated screen for MST to include lifetime
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experiences and trauma-related symptoms, thereby connecting more veterans, especially those
with PTSD, to the appropriate mental health services.
Co-morbid conditions. As mentioned above, PTSD is commonly associated with MST.
However, there are also other conditions with which PTSD is associated. For example, Zinzow
et al. (2007) reported that female veterans diagnosed with PTSD can have such co-occurring
disorders as depression, anxiety, and substance use. Hypertension, cardiovascular disease, and
sleep disorders are other illnesses that can be experienced by anyone – military, veteran, or
civilian – with PTSD (VVA, 2007). Schottenbauer, Glass, Arnkoff, Tendick, and Gray (2008),
in their review of non-response and dropout rates in outcome studies on PTSD, found that
homelessness and unemployment are common among veterans with PTSD, as well as other
populations. The NCPTSD (2010) has also noted conditions co-occurring with PTSD include
Acute Stress Disorder, Panic Disorder, self-harm/suicide, and traumatic brain injury.
Co-morbidities, which can accompany PTSD, make it a complex disorder to diagnose.
Veterans may present at VA Primary Care clinics to treat their physical symptoms; this is an
ideal place to treat illnesses like hypertension and cardiovascular disease as reported by the VVA
(2007) and mentioned above. However, the possibility of co-morbid mental health disorders like
PTSD needs to be addressed in the form of effective treatment modalities in the mental health
setting.
PTSD Treatment
Treatment types. Several different treatments are currently available for PTSD through
the VA. Pharmacotherapies, such as selective serotonin reuptake inhibitors (e.g., citalopram,
fluoxetine, and sertraline), serotonin-norepinephrine reuptake inhibitors (e.g., venlafaxine),
tricyclic antidepressants (e.g., amitriptyline), and, more recently, beta blockers (e.g.,
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propranolol), are usually used in combination with some form of psychotherapy (Sharpless &
Barber, 2011; NCPTSD, 2010; Vaiva et al., 2003). While there are numerous psychotherapies
available, including PE, CPT, EMDR, relaxation training, stress inoculation training,
interpersonal psychotherapy, and dialectical behavior therapy, the ones most commonly cited in
the literature are PE, CPT, and EMDR (Sharpless & Barber, 2011; Lee & Drummond, 2008;
Lilienfeld & Arkowitz, 2008; Rauch et al., 2009; Högberg et al., 2008; Lazrove, Triffleman,
Kite, McGlashan, & Rounsaville, 1998; NCPTSD, 2010).
Prolonged exposure ranges from 8 to 15 weekly sessions, with each session lasting a total
of 90 to 150 minutes, depending upon the VA facility in which it is administered. This therapy
attempts to modify memory structures underlying emotions, like the omnipresent fear associated
with traumatic events, by having a client revisit his or her trauma memories through imaginal
exposure (i.e., re-visiting and re-experiencing one’s trauma with their therapist through memory
and emotionally engaging in the memory). The client then describes aloud those memories and
any feelings he or she is experiencing. During and after processing of the trauma, a
psychoeducational component, aimed at teaching the client how to manage feelings and thoughts
associated with the trauma, and slowed breathing techniques are implemented (Rauch et al.,
2009; Sharpless & Barber, 2011; NCPTSD, 2010).
Cognitive processing therapy is usually administered in 12 individual or group weekly
sessions. Each session is 60 minutes in duration. This therapy has three stages. In the initial
stage, the impact of trauma and connection between thoughts and feelings are examined. In the
second stage, the meaning of the traumatic event(s) is explored to help clients challenge their
automatic thoughts, or stuck points, with a specific focus on self-blame. Clients write in detail
about their trauma and then read their accounts aloud, both to themselves and in their CPT
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sessions. During the third stage, clinicians assist clients in working through stuck points in their
narratives using cognitive behavioral strategies. By looking at the thoughts that may reflect
assimilation (e.g., “It was my fault my dad died”) or overaccomodation (e.g., “If I get too happy,
something bad will happen to me”), clients are often able to see where inaccurate conclusions
about self and others were drawn. At the end of this process, they are again asked to discuss the
impact of the traumatic events to determine how their thinking has changed and if their beliefs
have become more balanced (Sharpless & Barber, 2011; Högberg et al., 2008; Chard et al., 2010;
J. Wright, personal communication, April 16, 2012).
Eye movement desensitization and reprocessing therapy consists of a varied number of
sessions related to one’s personal circumstances and previous trauma. Each session is divided
into eight stages. These stages are carried out in the following order by the clinician: 1) client
history taking, during which time the client is evaluated for their presenting problem, coping
abilities, and possible root trauma(s) that may have lead up to their presenting problem, 2) client
preparation, which is used to inform the client of the EMDR process, perform a safe place
exercise, and teach a stress management technique, 3) assessment, which helps the client
determine which trauma memory to work on, 4) desensitization, during which bilateral
stimulation of some form, usually finger movements, is performed until the client is completely
desensitized to their trauma memory, 5) installation, during which the client holds the memory in
their mind while thinking of a new, positive thought to be associated with the memory, all while
bilateral stimulation is being performed, 6) body scan, which involves the client holding the
trauma and new belief in mind while scanning his or her body for any residual tension, 7)
closure, which is the process of ending a session, and 8) reevaluation, which occurs at the
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beginning of the next session and involves evaluating the client’s progress during the time
between sessions (Dworkin, 2003; Lilienfeld & Arkowitz, 2008; Lazrove et al., 1998).
Efficacy of PTSD treatments. Prolonged exposure and CPT have been met with
widespread positive reviews. A study by Rauch et al. (2009) of 10 veterans who had recently
returned from Iraq and Afghanistan found they showed significant reductions in PTSD
symptoms on post questionnaires and interviews after receiving between 7 and 21 sessions of
PE. Similarly, in a study of 65 civilians with PTSD, Hagenaars and van Minnen (2010)
determined that exposure therapy, another name for PE, offered in 8 to 12 weekly sessions that
lasted 45 minutes, resulted in increases in posttraumatic growth – this is positive change in one’s
emotional, cognitive, and social functioning as a result of learning new ways to process and
integrate traumatic events - after treatment and better overall treatment outcome. Schnurr et al.
(2007) concluded, through a randomized controlled trial (RCT) of PE therapy with female
veterans diagnosed with PTSD, those who received PE showed greater reductions in PTSD than
the control group which was administered present-centered therapy. PE was also one of only
two psychotherapies selected – the other being CPT – by the VA and DOD for expansive
dissemination within their healthcare facilities (Sharpless & Barber, 2011).
A meta-analysis of six studies examining the effectiveness of CPT found that it was
successful in alleviating PTSD symptoms associated with mild (e.g., loss of a pet) and severe
(e.g., witnessing death of a friend or family member) traumas for military and civilian
populations (Cahill, Rothbaum, Resick, & Folette, 2008). As mentioned earlier, Graca et al.
(2012) concluded CPT is an effective treatment for PTSD in a VA residential setting, based on
pre and post scores of three different test measures. A study utilizing an RCT in which Vietnam
veterans with PTSD were administered CPT therapy showed significant improvements in PTSD
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and comorbid symptoms immediately and one month after completion of treatment (Monson et
al., 2006). And, Friedman (2005) determined CPT and PE have met the most rigorous scientific
criteria for efficacy.
Eye movement desensitization and reprocessing therapy, on the other hand, has produced
mixed results within current research. Lazrove et al. (1998) found that, of seven adult
participants who completed three 90-minute sessions of EMDR, none met criteria for PTSD, as
stated in the Diagnostic and Statistical Manual-III-R (DSM-III-R; APA, 1987), two months after
treatment. Similarly, Högberg et al. (2008) found that 17 participants with chronic PTSD did not
meet criteria, as stated in the Diagnostic and Statistical Manual-IV (DSM-IV; APA, 1994),
directly after treatment, as well as at 8 and 35 months after treatment. A meta-analysis of seven
different psychotherapies, including EMDR, and based upon 33 RCTs, determined that EMDR
was effective in the civilian population (Bisson & Andrew, 2007). And, of all the literature
reviewed, none included or cited previous studies where EMDR was less effective than PE or
CPT.
However, in a study by Lee and Drummond (2008), EMDR, when administered to 48
participants over one session and measured one week later, reduced distress but not vividness
associated with traumatic memories. As mentioned earlier, a lack of strong empirical evidence
and theoretical groundwork (i.e., some scholars believe EMDR is based solely on imaginal
exposure and/or an educational structure) for EMDR are given as the main reasons by military
and veterans’ health agencies for continuing research into its effectiveness as a treatment for
PTSD (Sharpless & Barber, 2011; Institute of Medicine, 2007). Dworkin (2003), in his case
study analysis of EMDR as an effective therapy, did not dismiss it as invalid. Rather, he
suggested aspects of the therapeutic relationship that develop between the clinician and client
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during EMDR, including empathy, transference, and countertransference, are commonly
misunderstood, overlooked, or both, decreasing the apparent benefits the therapy has to offer.
Types of PTSD treatment programs. The VA offers several programs for the treatment
of PTSD. These services, as with any VA care, are offered to all veterans who have: a)
completed active military service in the Army, Navy, Air Force, Marines, Coast Guard, or
Merchant Marines During World War II or are National Guard members or reservists who have
completed a federal deployment in a combat zone and b) been discharged under other than
dishonorable conditions (NCPTSD, 2010).
Each program offers evaluation, education, and treatment. The program services include:
a) one-to-one mental health assessment and testing, b) medication, c) one-to-one psychotherapy
and family therapy, and d) group therapy, which covers topics like combat support, anger and
stress, and partner relationships. Additionally, every VA medical center has providers who are
trained to provide PTSD treatment.
Certain VA medical centers also offer one or both of two unique PTSD treatments. The
first is called Specialized Outpatient PTSD Programs (SOPPs). Three types of outpatient clinics
comprise SOPPs and allow veterans to meet with a provider on a regular basis: a) PTSD Clinical
Teams (PCTs) provide group and one-to-one treatment, b) Substance Use PTSD Teams (SUPTs)
treat the combined issues of PTSD and substance use, and c) Women’s Stress Disorder
Treatment Teams (WSDTTs) offer women veterans both group and one-to-one treatment.
The other unique PTSD treatment is comprised of Specialized Intensive PTSD Programs
(SIPPs). Treatment services are carried out in a therapeutic environment. Many of the
individual programs under SIPPs are residential, where veterans live at the VA facility during
treatment. Social, recreational, and vocational activities and counseling are part of SIPPs. The
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following are the specialized programs of SIPPs: a) outpatient PTSD Day Hospitals, which
provide one-to-one and group treatment for 4 to 8 hours per visit and are available on a daily
basis, b) Evaluation and Brief Treatment of PTSD Units (EBTPUs), which provide PTSD
treatment for a short time ranging from 14 to 28 days, c) PTSD Residential Rehabilitation
Programs (PRRPs), which offer PTSD treatment and case management, with the goal being to
help trauma survivors return to a healthy, functional way of living in their communities; stays in
this program are commonly 28 to 90 days long, d) Specialized Inpatient PTSD Units (SIPUs),
which offer trauma-focused treatment within a VA facility for an average length of 28 to 90
days, e) PTSD Domiciliary (PTSD Dom), which provides residential treatment for a set period of
time, with the goal being to assist veterans in improving their mental and physical health and
transitioning to outpatient mental health care, and f) Women’s Trauma Recovery Program
(WTRP), which is a 60-day residential program focused on war zone-related stress and MST and
allows veterans to work on their social skills so they may deal comfortably with others
(NCPTSD, 2010).
Discrepancies regarding PTSD treatment findings. The assorted findings regarding
PTSD treatment can be attributed to a number of study limitations including different sample
sizes, an unequal number of therapy sessions for each individual in each study, varied levels of
training for clinicians and researchers administering treatments, different types and numbers of
pre and post assessment instruments used to measure PTSD symptoms, and the tendency for
participants to have co-occurring mental health conditions (Sharpless and Barber, 2011; Lee and
Drummond, 2008; Lilienfeld and Arkowitz, 2008; Rauch et al., 2009; Högberg et al., 2008;
Lazrove et al., 1998). Additionally, Schottenbauer et al. (2008) claimed that major treatment
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dropout and non-response rates in studies of current empirically supported treatments for PTSD
reveal that these therapies do not successfully treat all patients.
Conclusion
The personal experience of traumatic events, such as abuse and death, can lead to the
development of PTSD, especially among military veterans. Those who use VA services
commonly present to primary health clinics, many with co-morbid conditions that are both
physical and mental in origin, making diagnosis and treatment challenging. However, a
summary of the literature reveals valuable information for the advancement of PTSD treatment.
Even though PE, CPT, and EMDR are currently supported by empirically-based evidence, future
research will help solidify their foundation as sound and effective PTSD treatments and offer
insight into ways they can be improved. Additionally, potential studies that sample the veteran
population can help clarify the effectiveness of these therapies within the VA. This research
project was developed for just that purpose. Particular attention was given to how treatment
outcomes are affected by and/or correspond to the following variables: age, gender, ethnicity,
and type of treatment received in the PTSD program. This method, in turn, provided insight into
the following research question posed for this project: How does a PTSD program offered
through the VA affect symptoms of PTSD and depression in veterans who have completed
treatment?
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Program Description
A PTSD residential treatment program in the mid-western United States was evaluated
for this project. This program was started in 2000 due to a need for specialized PTSD treatment
for the growing number of veterans with a PTSD diagnosis (J. Graca, personal communication,
June, 2009). It is part of this VA facility’s mental health services – primary care, surgical, urgent
care, acute psychiatric, telemedicine, extended care, rehabilitation, imaging, laboratory, and
pharmacy services are also offered here - and aims to help veterans struggling with residual
symptoms of traumatic events by improving their mental, physical, and social functioning (U. S.
Department of Veterans Affairs, 2011). Consisting of an approximately 8-week inpatient
treatment, this program represents part of the SIPPs, one of two unique PTSD treatments offered
by some VA facilities throughout the United States and mentioned above (NCPTSD, 2010).
The program is led by two psychologists and three social workers and supervised by the
Mental Health Service Line Director of the VA facility. All PTSD program staff members who
provide psychotherapy are certified to provide PE or CPT therapy, or both. Veterans who enter
into the program have a PTSD diagnosis established by a mental health professional prior to
admission. For the purposes of this project, diagnosis was confirmed by reviewing the veterans’
problem lists, psychiatric evaluations and/or psychological evaluations from their electronic
medical charts.
Initially, the PTSD program was limited to providing trauma exposure therapy for
combat veterans, which was considered the most effective therapy available at that time. This
therapy consisted of veterans meeting as a group of no more than eight participants four times a
week to discuss and process the traumatic effects of military combat. In 2007, this program
expanded to include offering CBT in a format combining group CPT with individual trauma
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processing, which is the same as the trauma exposure therapy previously offered exclusively,
except on an individual basis. The VA being evaluated in this project was one of the first VA
facilities to make this addition. Shortly after making this change, three evidenced-based
individual trauma processing therapies, PE, CPT, and EMDR, were made available in the
program. Currently, however, only CPT and PE are being offered.
Criteria for admission to the program include: a) established diagnosis of PTSD, b)
sobriety for 45 days prior to admission if the veteran had a prior substance abuse or dependence
diagnosis, c) stability on psychotropic medications, d) no suicide risk for at least two weeks prior
to admission, and e) a VA PTSD treatment program has not been completed in the last year.
Veterans enter the 45-day PTSD program as a cohort group of up to 16 veterans per group. After
the staff assesses the veteran’s needs, he or she is assigned to either the group trauma exposure
track or the CPT track. All veterans in the trauma exposure track have combat-related PTSD and
those in the CPT track have PTSD resulting from traumatic military non-combat and civilian
events.
Veterans in the CPT track are assigned an individual therapist for trauma processing.
The individual therapist provides either CPT or PE; the type of therapy administered is decided
upon by each veteran. All veterans in the CPT track participate 3 to 4 times weekly in a CBT
group focused on processing their cognitive distortions and negative beliefs. Veterans in the
trauma exposure track process their traumatic experiences in a group setting four times per week.
Veterans in both tracks attend PTSD psychoeducational and skill building groups together (e.g.,
stress management, seeking safety, spirituality, and anger management groups; J. Graca,
personal communication, August 22, 2011).
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All veterans who enter the PTSD program also receive a battery of clinical outcome
measures upon admission into and discharge from the program. These measures include the
Beck Anxiety Inventory (BAI), Beck Depression Inventory-II (BDI-II), PTSD Checklist (PCL),
and Posttraumatic Growth Inventory (PGI). Portions of the BDI-II and PCL data were analyzed
for this research project. Since the inception of this program, outcome data from these and other
measures have been collected to assess effectiveness, efficiency, and satisfaction as they relate to
the services provided. The outcome data management system was developed and has been
continually modified to conform to the Commission on Accreditation of Rehabilitation Services
(CARF) standards (2008).
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Method
Research Design
The purpose of this research project was to explore the effects of a mid-western VA
PTSD program on symptoms of PTSD and depression in military veterans who participated in
the program. A quantitative design in the form of a secondary data analysis of available data was
utilized.
Population and Sample
The population from which the sample was drawn for this project included all veterans,
male and female and from all ethnic/racial backgrounds, who have: a) completed active military
service in the Army, Navy, Air Force, Marines, Coast Guard, or Merchant Marines During
World War II or are National Guard members or reservists who have completed a federal
deployment in a combat zone and b) been discharged under other than dishonorable conditions
(NCPTSD, 2010). A non-probability sample of convenience was developed and consisted of
124 veterans who meet the following inclusion criteria: a) diagnosis of PTSD, which was
verified through review of the sample participants’ problem lists, psychiatric evaluations, and/or
psychological evaluations listed in their electronic medical charts, b) admission to a 45-day
PTSD treatment program at a mid-western VA health facility between August, 2006 and
September, 2009, followed by completion of treatment, and c) completion of pre, post, 6-, and
12-month follow-up BDI-II and PCL measures. Those who did not meet all of the above
inclusion criteria were excluded from the sample.
A non-probability sampling design was chosen for this project because of the researcher’s
access to statistical data she collects for the PTSD program in the mid-western VA facility at
which she is employed as a psychometrist, or a person who administers, scores, and sometimes
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interprets test data. The readily available data was easily collected and de-identified by the
Research Coordinator at this VA facility to perform a secondary data analysis of pre, post, and
follow-up test scores.
Protection of Human Subjects
Protection of the sample participants was maintained during and after the collection,
analysis, and dissemination of data utilized. This safeguard was accomplished through several
steps. First, the electronic data currently used by the researcher as part of her employment duties
was copied and placed in a secure electronic folder accessible to only the VA facility’s Research
Program Coordinator, Privacy Officer, and Information and Security Officer. Informed consent
from participants represented by the data was not needed, as this project is implemented a
secondary data analysis. Participants gave informed consent in conjunction with Health
Insurance Portability and Accountability Act (HIPAA) guidelines upon their admission into the
PTSD program. A waiver of HIPAA authorization was obtained through a VA Institutional
Review Board (IRB; personal communication, G. Palmer, November 14, 2011). Only one
anticipated risk to participants, the breach of confidentiality through use of their medical records,
existed. No direct benefits from this project existed for participants.
Second, the Research Program Coordinator de-identified the data by removing names,
social security numbers, and dates of admission, discharge, and follow-up testing gathered as
part of the PTSD program. However, a master list that does include these identifying factors was
maintained by the Research Program Coordinator according to VA policy, which dictates that a
master list of all samples used in VA research projects be saved in case the VA facility is audited
(G. Palmer, personal communication, August 31, 2011). Though anonymity was somewhat
compromised by having a master list to connect data to participants, confidentiality was
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maintained at all times by not releasing any identifying information to anyone other than the
Research Program Coordinator, Privacy Officer, and Information Security Officer. Persons in
these positions oversee security of VA data, including that which is collected for research
purposes, as part of the VA’s mission to maintain federal laws which protect veterans’ health
care and records.
Third, the Research Program Coordinator placed the de-identified data in a separate
electronic folder accessible to him, the researcher, and the VA facility’s Privacy and Information
Security Officers. The researcher accessed this data only for the purposes of analysis and
interpretation of project findings. After completion of this clinical research project in May of
2012, all de-identified data was stored permanently by the Research Program Coordinator in a
secure electronic folder accessible only to the three individuals noted above (i.e., VA Research
Program Coordinator, Privacy Officer, and Information Security Officer), as well as the
Research Compliance Officer.
Fourth, a proposal was submitted to the University of Saint Thomas (UST) IRB. The
researcher made all corrections and changes as suggested by the IRB in order to begin data
collection and analysis and complete this research project in a timely manner.
And fifth, in order to use VA data as part of this project, an abstract and protocol (see
Appendices B and C, respectively) – these are the required documents for any VA research –
were submitted to the VA facility’s Research and Development (R&D) Committee. This
committee recommended minor changes to each of these documents, including a description of
how a PTSD diagnosis is established for participants and minor grammatical corrections. The
researcher made these changes by clarifying the manner in which a PTSD diagnosis is
established (i.e., it is conducted prior to program admission by a mental health professional and
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verified later, during data collection and retrospective medical chart reviews) and by editing the
VA Abstract and Protocol to reflect R&D recommendations for grammatical improvements. The
VA Abstract and Protocol were submitted to an IRB located within a larger, neighboring VA
facility and accepted by this IRB on October 28, 2011. Once changes suggested by the VA IRB
were made to the abstract and protocol, the researcher re-submitted them to the R&D Committee
at the VA facility where she works. The R&D Committee suggested final changes on December
14, 2011. These final alterations were made, allowing the researcher to begin data collection and
analysis starting on January 5, 2012.
Data Collection
Data were collected from a PTSD treatment program located at a VA facility in the midwestern United States. This program is part of the mental health services offered at the VA,
which also provides primary care, surgical, urgent care, acute psychiatric, telemedicine, extended
care, rehabilitation, imaging, laboratory, and pharmacy services. It was developed in 2000 and
offered group trauma exposure to tracks of eight veterans at a time. In 2007, the PTSD program
expanded and split into two separate tracks, with up to eight veterans in each track. One track
consists of only combat veterans who receive group trauma exposure therapy. The other track
consists of veterans who have experienced any type of trauma, military-related or otherwise; this
track receives a combination of individual CPT or PE therapy and CBT therapy. Veterans in
both tracks attend skill building groups to improve their mental and social functioning.
This program is part of the SIPPs, one of two unique PTSD treatments offered by some
VA facilities throughout the United States and mentioned above (NCPTSD, 2010). It is led by
two psychologists and three social workers and supervised by the Mental Health Service Line
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Director of the VA facility. All PTSD program staff members who provide psychotherapy are
certified to provide PE or CPT therapy, or both.
Data collected via in-person and phone administration of testing between August, 2006,
and September, 2009, as part of the researcher’s position as a VA psychometrist was analyzed.
It included pre, post, 6-, and 12-month follow-up program scores from the BDI-II and PCL. A
retrospective chart review of each participant was also conducted to gather limited demographic
information, including age, gender, ethnicity, and the type of therapy (i.e., PE or CPT) received.
The BDI-II was a revision of the Beck Depression Inventory (BDI), developed in 1966.
This revision was made in response to the APA’s publication of the DSM-IV, which modified
many of the diagnostic criteria for Major Depressive Disorder and increased the construct and
content validity of the BDI-II (Beck, Steer, Ball, & Renieri, 1996). There are 21 questions on the
BDI-II, which can be presented both orally and in written or computerized form. Each answer is
rated on a scale of 0-3, with 0 indicating no endorsement of a depression symptom and 3
indicating endorsement of the severest form of that symptom. All item scores are summed for a
total score; 0-13 indicates minimal depression, 14-19 indicates mild depression, 20-28 indicates
moderate depression, and 29-63 indicates severe depression. The BDI-II is considered reliable
and valid, as it is positively correlated with the Hamilton Depression Rating Scale (r=0.71) and
has been shown to have a high 1-week test-retest reliability (r=0.93), suggesting it is not overly
sensitive to daily mood variations. The test also has high internal consistency (α=0.91; Beck,
Steer, & Brown, 1996).
The PCL is a self-report measure used to screen for and diagnose PTSD, as well as track
PTSD symptom changes before and after clinical treatments. It was developed by Frank
Weathers and his colleagues at the NCPTSD in 1993. The PCL consists of 17 items and comes
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in military (PCL-M), civilian (PCL-C), and specific event (PCL-S) versions; the specific event
version is used in the VA PTSD program being evaluated for this project. Each answer is rated
on a scale of 1-5, with 1 indicating no experience of a PTSD symptom related to the responder’s
specific traumatic event and 5 indicating the severest experience of that symptom. All item
scores are summed for a total score. A score of 50 or greater generally indicates a positive
screen for PTSD, though this cutoff score is subject to variation, based on the VA clinic in which
it is administered and the type of trauma addressed (NCPTSD, 2010). All versions of the PCL
are considered reliable and valid. The PCL-S is positively correlated with the Clinician
Administered PTSD Scale (r=0.93) and has shown excellent test-retest reliability (r=0.80) and
internal consistency (α=0.86) for total PCL-S scores (Blanchard, Jones-Alexander, Buckley, &
Forneris, 1996; Norris & Hamblen, 2003).
Data Analysis
This quantitative case-control study utilized retrospective data to evaluate a PTSD
treatment program in a mid-western VA facility. Total scores for the BDI-II and PCL,
administered before, immediately after, and 6 and 12 months after completion of the program,
were previously collected for evaluation purposes. After being de-identified, the data were
stored on an Excel spreadsheet and analyzed at the VA facility.
Data analysis was carried out using the Statistical Package for the Social Sciences (SPSS)
Version 20.0 software. Preliminary analyses were conducted to determine similarities between
groups for age using analysis of variance (ANOVA), as well as for gender and ethnicity using
chi-square tests. Multivariate analyses of covariance (MANCOVAs) were conducted on
outcome dependent variables, and the pretreatment scores on the BDI-II and PCL were assigned
as covariates. For statistical analysis of overall main effects, alpha was set to p < .05.
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Independent variables were subjects who received PE, CPT, EMDR, or group trauma processing
therapy. Dependent measures were the post, 6-month follow-up, and 12-month follow-up BDI-II
and PCL scores. Multivariate analysis of covariance was determined to be advantageous for
several reasons: a) MANCOVA allows for analysis of several dependent variables, b) the
procedure is robust to potential violations of the assumption of normality for dependent
variables, particularly with larger sample sizes, and 3) using the pretest scores as covariates will
reduce the error variance and systematic bias. With nonrandomized designs, MANCOVA (as
with analysis of covariance or ANCOVA) is used to adjust the posttest mean scores for
differences among groups on the pretest means scores because such differences are likely to
occur with intact groups (Dimitrov & Rumrill, 2003). One disadvantage of MANCOVA is that
it is sensitive to outliers in the covariate. Data was examined for outliers and none that were
significant were found and removed.
Additionally, post hoc t-tests were run within groups to compare pre, post, and follow-up
scores of the BDI-II and PCL and reveal any significant changes in depression and PTSD
symptoms over time. The calculation of effect sizes was analyzed to determine the clinical and
statistical significance of changes in BDI-II and PCL scores over time. For the purposes of this
study, effect sizes, based on partial eta squared (ηp2) values, were as follows: small = .01,
medium = .06, and large = .14 (Cohen, 1988). And, correlations were run with demographic
variables, including age, gender, and pre, post, and follow-up scores, to examine potential
additional relationships among the data collected.
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Results
Data Analysis Sample
The original sample obtained for secondary data analysis in this project consisted of 128
participants. However, as mentioned above, two participants did not complete the PTSD
treatment program, even though they had completed testing at all points of test score
measurement (i.e., pre, post, 6-month follow-up, and 12-month follow-up). Two additional
participants in the CPT group were divided into their own group of therapy which consisted
solely of individual therapy while the group therapy component to their treatment was missing.
Because of the small sample size created by this group, as well as the failure of the first two
participants to complete treatment – one inclusion criterion for this project – all four were
excluded from the final sample of participants whose data was analyzed and reported in this
section. No participants’ scores were determined to represent extreme outliers. Therefore, 124
cases were used for full analysis. Tests of homogeneity revealed that data adequately met
assumptions of normality to allow for further statistical analyses without need for additional data
transformation.
The characteristics of the sample are presented in Table 1, which includes age, gender,
ethnicity, and type of treatment received. Group trauma processing was included as a point of
comparison since a portion of the sample participants only received this type of therapy. Mean
age ranged from 47 to 58 years (SD = 14.70 to 12.10, respectively), depending upon the
treatment group to which participants were assigned. Most of the sample consisted of Caucasian
males. The largest treatment group (n=65) was group trauma processing (i.e., the exclusive
treatment for participants in the exposure track) and the smallest treatment group (n=8) was
EMDR.
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Table 1
Demographic Characteristics of the Sample
______________________________________________________________________________
Characteristic

PE

CPT

EMDR

GPT

(n = 11)

(n = 40)

(n = 08)

(n = 65)

Age

Test, p- value
__________________
F(3, 120) = 0.84, p=.48

M

51.91

52.55

47.13

53.58

(SD)

(9.20)

(8.74)

(14.70)

(12.10)
X2(3) = 3.35, p=.34

Gender
Male

10 (90.9%)

38 (95.0%)

7 (87.5%)

64 (98.5%)

Female

1 (9.1%)

2 (5.0%)

1 (12.5%)

1 (1.5%)
X2(6) = 10.88, p=.09

Ethnicity
Caucasian 11 (100%)

31 (77.5%)

6 (75.0%)

61 (93.8%)

African Am. 0 (0.0%)

6 (15.0%)

2 (25.0%)

3 (4.6%)

Native Am. 0 (0.0%)

3 (7.5%)

0 (0.0%)

1 (1.5%)

______________________________________________________________________________
Note. PE = prolonged exposure therapy; CPT = cognitive processing therapy; EMDR = eye movement
desensitization and reprocessing therapy; M = mean; SD = standard deviation.

Preliminary Data Analysis
Preliminary data analysis was conducted with the demographic variables of age, gender,
and ethnicity. Analysis of variance (ANOVA) comparing age differences between groups
revealed no significant findings [F(3, 120) = .84, p =.48]. Differences in gender were not
significant between groups [x2(3) = 3.35, p = .34]. Finally, there were no significant differences
in ethnicity between groups [x2(6) = 10.88, p = .09]. As revealed in Table 1, the vast majority of
subjects were Caucasian. Given results of preliminary analyses, it was concluded the treatment
groups were sufficiently matched on demographic variables of age, gender, and ethnicity.
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Additionally, correlations between age, gender, and test scores revealed no significant
relationships.
Multivariate Analysis of Covariance
The results of the MANCOVA, as presented in Tables 2 and 3, demonstrated a significant
main effect for pre and post scores on the BDI-II [Wilk’s Lambda = .66, F(3, 117) = 20.41, p <
.001, ηp2 = .34], and PCL [Wilk’s Lambda = .77, F(3, 117) = 11.68, p < .001, ηp2 = .23]. The
overall effect size was large for scores on the BDI-II and PCL. However, the overall main effect
for type of treatment was not significant.
Table 2
Between and Within Group Effects for the BDI-II With Pretreatment Condition as Covariate
______________________________________________________________________________
Variable

PEb

CPTc

EMDRd

GTPe

F

p

ηp2

(Est. Mean
(MANCOVA)
+
SEa)
______________________________________________________________________________
Post-Testf 24.59 + 3.20 23.56 + 1.68 29.17 + 3.78 23.32 + 1.31 31.47

p < .001

0.21

6-Monthf

33.61 + 3.21 35.31 + 1.68 33.99 + 3.79 31.79 + 1.32 42.10

p < .001

0.26

12-Monthf 33.66 + 3.19 33.46 + 1.67 31.91 + 3.77 32.04 + 1.31 52.11

p < .001

0.31

_____________________________________________________________________________________________
Note. aSE = standard error; bPE = prolonged exposure therapy; cCPT = cognitive processing therapy; dEMDR = eye
movement desensitization and reprocessing therapy; eGTP = group trauma processing therapy. fCovariates
appearing in the MANCOVA were evaluated with the BDI-II Pre value = 31.36.
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Table 3
Between and Within Group Effects for the PCL With Pretreatment Condition as Covariate
__________________________________________________________________________
Variable

PEb

CPTc

EMDRd

GTPe

F

p

ηp2

(Est. Mean
(MANCOVA)
+
SEa)_____________________________________________________________________
Post-Testf 52.94 + 4.24 53.87 + 2.22 52.52 + 4.96 54.95 + 1.74 14.76 p < .001 0.11
6-Monthf

60.94 + 3.40 59.22 + 1.78 62.14 + 3.97

58.88 + 1.39 22.95 p < .001 0.16

12-Monthf 62.03 + 3.69 61.50 + 1.93 61.13 + 4.31 60.17 + 1.51 28.90 p < .001 0.20
___________________________________________________________________________

Note. aSE = standard error; bPE = prolonged exposure therapy; cCPT = cognitive processing therapy; dEMDR =
eye movement desensitization and reprocessing therapy; eGTP = group trauma processing therapy. fCovariates
appearing in the MANCOVA were evaluated with the PCL Pre value = 63.85.

Post-Hoc T-Tests
Post-hoc analyses for within-group differences were concluded with t-tests. Table 4
illustrates significant findings from the BDI-II scores for each of the treatment conditions
regarding within-group differences. No significant differences were found between pretreatment and other conditions for PE. Significant differences were found between pre-treatment
and post-treatment conditions for CPT [t(39) = 3.30, p < .01], as well as pre-treatment and 6month follow-up conditions [t(39) = -2.08, p < .05]. Unfortunately, scores were significantly
higher on the 6-month follow-up condition when compared to the pre-treatment condition. No
significant difference was found between baseline and 12-month follow-up conditions. For
EMDR, no significant differences were found between pre-treatment and other conditions. For
group trauma processing, significant differences were revealed between pre-treatment and posttreatment conditions [t(64) = 5.74, p < .001].
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Table 4
Performance on Self-Report Measures for Each Group for the BDI-II
_____________________________________________________________________________
PEa

CPTb

EMDRc

GTPd

(n = 11)

(n = 40)

(n = 08)

(n = 65)

Between

M(SD)

M(SD)

M(SD) _____

M(SD)

Groups _

Pre

28.64 (9.71)

30.78 (12.27)

37.38 (14.66)

31.45 (11.95)

Post

23.36 (14.25)

23.30 (11.49)**

31.88 (12.69)

23.35 (11.57)***

NS

6-Month

32.18 (15.19)

35.00 (9.51)*

37.13 (9.36)

31.83 (13.56)

NS

12-Month

32.09 (10.91)

33.13 (10.16)

35.38 (10.65)

32.09 (14.29)

NS

Measure

p-value

______________________________________________________________________________

Note. a PE = prolonged exposure therapy; bCPT = cognitive processing therapy; cEMDR = eye movement
desensitization and reprocessing therapy; dGTP = group trauma processing therapy. *Post hoc testing within groups
signifies significant difference between pretreatment condition and follow-up condition p < .05; **Post hoc testing
within groups signifies significant difference between pretreatment condition and follow-up condition p < .01;
***Post hoc testing within groups signifies significant difference between pretreatment condition and follow-up
condition p < .001.

Table 5 shows significant within-group differences on the PCL for each of the treatment
conditions. For PE, significant differences were found between pre-treatment and post-treatment
conditions [t(10) = 2.79, p < .05]. For CPT, significant differences were found between pretreatment and post-treatment conditions [t(39) = 4.99, p < .001], as well as pre-treatment and 6month follow-up conditions [t(39) = 3.06, p < .01]. While the mean value of scores for the 6month follow-up condition was still significantly lower than that for the pre-treatment condition,
it began to approach the pre-treatment mean value. No significant difference was found between
baseline and 12-month follow-up conditions, also showing the 12-month follow-up mean value
was approaching the pre-treatment mean value. For EMDR, no significant differences were
found between pre-treatment and other conditions. For group trauma processing, significant
differences were found between pre-treatment and post-treatment [t(64) = 4.63, p < .001], pre31

treatment and 6-month follow-up [t(64) = 2.84, p < .01], and pre-treatment and 12-month followup conditions [t(64) = 2.02, p < .05]. No significant difference was found between baseline and
6-month follow-up conditions.
Table 5
Performance on Self-Report Measures for Each Group for the PCL
_____________________________________________________________________________
Measure

PEa

CPTb

EMDRc

GTPd

p-value

(n = 11)

(n = 40)

(n = 08)

(n = 65)

Between

M(SD)

M(SD)

M(SD) _____

M(SD)

Groups ___

Pre

60.09 (09.22) 64.83 (10.62)

66.63 (16.04)

63.54 (10.93)

Post

51.27 (16.24)* 54.30 (14.62)***

53.75 (17.09)

54.82 (14.34)***

NS

6-Month

59.27 (13.17) 59.65 (11.53)**

63.38 (07.37)

58.74 (12.84)**

NS

12-Month

60.00 (13.37) 62.03 (12.89)

62.63 (06.82)

60.00 (14.42)*

NS

______________________________________________________________________________

Note. a PE = prolonged exposure therapy; bCPT = cognitive processing therapy; cEMDR = eye
movement desensitization and reprocessing therapy; dGTP = group trauma processing therapy.
*Post hoc testing within groups denotes significant difference between pretreatment condition and follow-up
condition p < .05; **Post hoc testing within groups denotes significant difference
between pretreatment condition and follow-up condition p < .01; ***Post hoc testing within
groups denotes significant difference between pretreatment condition and follow-up
condition p < .001.
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Discussion
This project offers valuable information about the outcome of PTSD treatment using
different psychotherapies in a residential VA setting. The results support previous findings that
PE, CPT, and EMDR are all beneficial when examined for their effectiveness before and after
the completion of therapy (Rauch et al., 2009; Hagenaars & van Minnen, 2010; Schnurr et al.,
2007; Sharpless& Barber, 2011; Cahill et al., 2008; Graca et al., 2012; Monson et al., 2006;
Friedman, 2005; Lazrove et al., 1998; Högberg et al., 2008; Yoder et al., 2012). However, the
questionable efficacy of the therapies over time, as revealed by the follow-up and overall data
analyses, requires further examination to determine the context of this project’s findings, as well
as future implications for using psychotherapy as a form of PTSD treatment for veterans.
Summary of Findings
The large effect size revealed between BDI-II pre and post scores shows participants
experienced a significant decline in symptoms of depression, irrespective of the treatment
modality used over the course of PTSD treatment. Contrary to previous conclusions (Rauch et
al., 2009; Hagenaars & van Minnen, 2010; Schnurr et al., 2007; Sharpless& Barber, 2011; Cahill
et al., 2008; Graca et al., 2012; Monson et al., 2006; Friedman, 2005; Lazrove et al., 1998;
Högberg et al., 2008), a similar decline in symptoms of PTSD over the course of treatment was
not evident. Additionally, the type of treatment received by participants (i.e., PE, CPT, EMDR,
or group trauma processing) did not affect the degree of symptomatology they endorsed for
depression and PTSD at any point of treatment measurement. These findings suggest
depression, more so than PTSD, can be positively affected by various types of PTSD treatment
in a residential VA facility.
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An examination of differences in mean scores for the BDI-II and PCL measures reveals
interesting trends in progression of symptoms over time. For the BDI-II, there was a significant
decline in scores from pre- to post-treatment when CPT and group trauma processing therapy
were applied and a similar pattern appeared, albeit much weaker, when PE and EMDR were
utilized. This finding demonstrates that all treatment modalities examined in this project were
effective to varying degrees in reducing symptoms of depression throughout the course of
treatment. However, because BDI-II scores increased at 6- and 12-month follow-up points of
measurement to nearly meet or exceed the pre-treatment scores, it appears the sample of veterans
in this project was not able to maintain the treatment effect of minimized symptomatology longterm.
Comparable results were obtained from PCL mean scores. There was a significant
decline in scores from pre- to post-treatment for all types of treatment, though EMDR revealed
this change to a lesser degree than was apparent in the other treatment modalities (i.e., PE, CPT,
group trauma processing). Scores at 6- and 12-month follow-up points of measurement again
approached or exceeded pre-treatment scores; these results differ significantly from previous
research findings that have shown decreased PTSD symptomatology 5-10 years after completion
of PTSD treatment (Resick, Williams, Suvak, Monson, & Gradus, 2011). Akin to symptoms of
depression during and after treatment, the PCL scores revealed the veteran sample was not able
to maintain decreased symptomatology long-term.
Strengths and Limitations
There are several strengths inherent in this clinical research project. First, it utilized data
collected from a large sample of veterans with PTSD, enhancing the knowledge base for PTSD
treatment offered within VA facilities. Second, only one participant was excluded from the
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initial sample due to having dropped out of treatment early, minimizing the influence of attrition
on this project’s results. Third, the use of follow-up data, which is rare in clinical practice
settings, serves to inform the course of symptomatology for depression and PTSD before and
after treatment. Fourth, the number of statistics used offers an array of information about the
effects of treatment on PTSD among military veterans. Fifth, any relationships revealed between
demographic variables and scores on the BDI-II and PCL can influence future PTSD treatment
modalities, both within the VA and DOD. And sixth, findings from this project may be
generalized to similar PTSD residential treatment settings within the VA.
However, there are also limitations to this project. First, the data used comes from a
treatment, rather than randomized, sample, making generalizability to all veterans or the general
population improbable. Second, while a low dropout rate is advantageous to the validity of this
project’s findings, it can also be viewed as a limitation; veterans have been found to exhibit
strong help-seeking behaviors because the presence of illness can ensure the continuation of
government benefits, making them less likely to drop out than non-veteran research samples
(Schottenbauer et al., 2008). Third, the subsamples created by each treatment group were
unequal (i.e., EMDR had the smallest group and group trauma processing had the largest).
Although overall significant main effects of MANCOVA partially addressed problems with
unequal cell sizes, it may not have been sufficient for post-hoc analyses. Therefore, post-hoc
analyses may not have detected significant treatments effects due to small sample size. Fourth,
lack of a control group, which is useful in determining the effects of possible confounding
variables, further weakened the methodological rigor of the project. Fifth, only the total scores
of two measures, the BDI-II and PCL, and limited demographic information were examined. An
analysis of scores from a larger group of psychometric measures, as well as a collection of
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several demographic characteristics would provide a clearer picture of how PTSD treatment
within the VA and military veterans diagnosed with PTSD intersect. Sixth, a secondary data
analysis implies the data have been previously collected and are in final form at the time of
analysis, thereby preventing opportunities to research an array of variables. And finally, the data
were collected via in-person and telephone testing administrations, with phone administrations
administered solely by a female and in-person testing administered by both a male and female.
These factors could have biased the way in which subjects responded to test items.
Implications
The findings of this research project offer valuable insight into the dynamics of PTSD
treatment in a residential VA facility but also raise questions about its long-term efficacy. First,
in the area of future research, attention needs to focus on the use of large, diverse sample
populations (e.g., to include gender, age, ethnicity, wartime experience, co-morbid health factors,
support systems, medications used, psychiatric hospitalizations) so as to accurately represent the
ways in which PTSD treatment is experienced by individuals of all backgrounds. Second, a
larger array of sound data collection methods (e.g., interviews, questionnaires, psychometric
instruments, case studies, RCT experiments, field observations) needs to be employed so as to
gain a greater understanding of the best ways to record content related to factors affecting PTSD
treatment in a VA facility. And third, since most research focuses on how PTSD symptoms are
affected by evidence-based therapies like PE, CPT, and EMDR (Rauch et al., 2009; Hagenaars &
van Minnen, 2010; Schnurr et al., 2007; Sharpless& Barber, 2011; Cahill et al., 2008; Graca et
al., 2012; Monson et al., 2006; Friedman, 2005; Lazrove et al., 1998; Högberg et al., 2008),
future research endeavors could help clarify how these therapies, as well as other residential
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treatment factors (e.g., socialization, behavioral activation, and medication stability/compliance),
affect depression symptoms.
Many practice implications also exist. First, clinicians need to develop highly
individualized assessments and treatment plans for veterans, as well as non-veterans. By doing
this, each person will be matched with the best method of treatment to meet their personalized
needs. Second, when meeting with veterans who have completed PTSD treatment in a VA
residential setting, clinicians should carefully assess the long-term effectiveness of treatment by
exploring contributing factors; these include social support systems, housing needs, mental
health and/or substance use diagnoses, financial and legal status, coping skills, motivation to
change, possible secondary gains of remaining mentally ill to receive uninterrupted VA
compensation, and previous treatment/therapy experiences (Kutter et al., 2004). Awareness of
the chronic nature of PTSD and the trend towards a partial regression of symptoms after
completion of treatment can also assist clinicians in gauging how effective previous PTSD
treatments have been (J. Wright, personal communication, April 16, 2012). Third,
comprehensive knowledge of each evidence-based practice examined in this project (i.e., PE,
CPT, and EMDR), as well as group trauma processing, can ensure an accurate and uniform
delivery of therapy. Inconsistent therapy procedures, whether administered by different
clinicians or the same clinician, can significantly affect alleviation of symptoms originating from
PTSD, depression, and other mental health disorders.
Finally, certain policy issues are evident. First, feedback from veterans, their families
and friends, and professionals about experiences with VA-based PTSD treatment and its longterm effects on mental health can greatly influence the construction of comprehensive VA
policies and procedures, leading to more effective, cost-efficient services. Second, nationwide
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education, within both VA facilities and their surrounding communities, about the components of
effective PTSD treatment and aftercare may convince policymakers to allocate greater funding
for PTSD-related services within the VA. Third, the VA and DOD can combine their anecdotal
and empirical data (e.g., from research projects such as this) to streamline PTSD services and
promptly address the consequences of this disorder for individuals as they transition from
military to veteran health care.
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Conclusion
Posttraumatic stress disorder has long plagued military personnel and veterans. The
complexity with which it manifests itself, commonly co-occurring with other biopsychosocial
factors, has made assessment and treatment within the VA setting challenging. However, the
VA has responded proactively with the development of several different programs aimed at
treatment and management of PTSD symptoms. As an example of current research, this project
has revealed findings that support PE, CPT, and EMDR, as well as group trauma processing, as
effective treatments within a residential VA facility. Future endeavors are needed, though, to
inform the direction of research, practice, and policy, thereby upholding the VA’s mission to
consistently provide competent, effective care to every veteran served.
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Appendix A
ABSTRACT
Protocol: Effects of Posttraumatic Stress Disorder (PTSD) Treatment Offered in a Veterans
Administration (VA) Mental Health Facility on Veterans’ PTSD and Depression Symptoms.
Principal Investigator: Glen Palmer, PhD, ABN
Co-Investigator: Kylene Occhietti, BS
Objective/Hypothesis: The purpose of this project is to conduct a non-randomized comparative
study of the effectiveness of the three evidence-based psychotherapies (i.e., PE, CPT, and
EMDR), offered in a residential clinical setting, on veterans’ symptoms of PTSD and depression.
The study will test the following hypotheses:
1) Veterans who receive any of the evidence-based individual psychotherapies (i.e., PE,
CPT, or EMDR, when it was still being offered at the Saint Cloud VA) will show a
reduction in symptoms of PTSD and depression upon discharge from the program, a
slight increase in symptoms at the 6-month follow-up and a leveling off of symptom
intensity by the 12-month follow-up. These findings will vary by veterans’ demographic
characteristics, including age and ethnicity.
2) There will be no significant differences between PE, CPT, and EMDR in their effect on
veterans’ symptoms of PTSD and depression.
Research design/Methodology: All veterans who were admitted to the Saint Cloud PTSD
residential program from August, 2006 to September, 2009 and completed pre, post, 6-, and 12month follow-up measures are to be included in the sample. Criteria for admission to the
program includes: a) established diagnosis of PTSD, b) sobriety for 45 days prior to admission if
the veteran had a prior substance abuse or dependence diagnosis, c) stability on psychotropic
medications, d) no suicide risk for at least two weeks prior to admission, and e) the veteran has
not completed a PTSD program in the last year. All veterans who enter the Saint Cloud PTSD
program receive a battery of clinical outcome measures upon admission into and discharge from
the program. These measures include the Beck Anxiety Inventory, Beck Depression InventoryII, PTSD Checklist, and Posttraumatic Growth Inventory. Outcome data from the Beck
Depression Inventory-II and PTSD Checklist from the Saint Cloud PTSD residential program
will be utilized. A chart review will also be conducted to gather some demographic information
(i.e., gender, age, and ethnicity) and type of therapy received on subjects included in the sample.
Analyses of outcomes will include comparisons of pre- and posttest measures and follow-ups.
ANOVAs, t-tests, and correlations will be used for continuous variables. Chi-square tests will be
used for nominal or categorical data. Regression analysis will also be used for continuous and/or
categorical variables.
Clinical Significance: The most recent literature regarding the best evidence-based therapies
for PTSD form a consensus that PE, CPT, and EMDR are, indeed, evidence-based. However,
this research also shows studies with veteran samples in which pre, post, 6-, and 12-month
follow-up test data from their PTSD treatment is limited. This proposed comparative study will
explore the effectiveness of PE, CPT, and EMDR on symptoms of PTSD and depression over
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time, as well as provide valuable information for the future of the Saint Cloud PTSD program
and other PTSD residential treatment settings in the VA.
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Appendix B
Protocol: Effects of Posttraumatic Stress Disorder (PTSD) Treatment Offered in a Veterans
Administration (VA) Mental Health Facility on Veterans’ PTSD and Depression Symptoms.
Principal Investigator: Glen Palmer, PhD, ABN
Co-Investigator: Kylene Occhietti, BS
Background: The military veteran population, having endured the conflicts of war to secure the
freedoms of the United States, has received national attention for the struggles some of its
members have had with posttraumatic stress disorder (PTSD). PTSD is characterized by
symptoms of avoidance, emotional numbing, and hyperarousal to stimuli that remind one of a
traumatic event(s) he or she has experienced (e.g., military combat, rape, being witness to the
violent death of a friend or family member, Dworkin, 2003).
Prevalence estimates show, for those veterans who have served in Operations Enduring Freedom
and Iraqi Freedom (OEF/OIF), approximately 15% or more have developed PTSD (Shiner,
2011), compared to 30% and 26%, respectively, of male and female Vietnam war veterans,
approximately 10% of Gulf War veterans, and 8% of veterans deployed to Somalia (Friedman,
2005). Between 1999 and 2004, the number of veterans who reported PTSD increased from
120,265 to 215, 871. During this same time period, veterans’ compensation for developing
PTSD as a result of their military duties rose from 1.72 to 4.28 billion dollars (Committee on
Veterans’ Compensation for PTSD, 2007; Institute of Medicine [IOM] and National Research
Council, 2007).
Based on the rising cases and mental and physical health costs of PTSD (Shiner, 2011), Congress
has allotted considerable funding to the Department of Veterans Affairs (VA) and the
Department of Defense (DOD, Levin, 2011). The VA has used its portion of this funding to
research and offer the best care available to its veterans. Currently, PTSD is treated within the
VA using a number of different pharmacologic (e.g., selective serotonin reuptake inhibitors and
serotonin-norepinephrine reuptake inhibitors) and/or psychotherapeutic (e.g., cognitive
behavioral therapy [CBT], brief psychodynamic psychotherapy, and family and group therapy)
interventions in residential and outpatient settings (Sharpless and Barber, 2011; National Center
for PTSD [NCPTSD], 2010). More recently, PTSD treatment programs offered by the VA have
focused on two evidence-based CBT treatments that have been shown to be very successful in
treating PTSD: Cognitive Processing Therapy (CPT) and Prolonged Exposure (PE, NCPTSD,
2010).
Prolonged exposure and CPT have been met with widespread positive reviews. A study by
Rauch et al. (2009) of 10 veterans who’d recently returned from Iraq and Afghanistan found they
showed significant reductions in PTSD symptoms on post questionnaires and interviews after
receiving between 7 and 21 sessions of PE. Similarly, in a study of 65 civilians with PTSD,
Hagenaars and van Minnen (2010) found exposure therapy offered in the form of 8 to 12 weekly
sessions lasting 45 minutes, resulted in increases in posttraumatic growth after treatment and
better overall treatment outcome. Furthermore, PE and CPT were the only two psychotherapies
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selected by the VA and DOD for expansive dissemination within their healthcare facilities
(Sharpless and Barber, 2011).
A meta-analysis of six studies examining the effectiveness of CPT found that it was successful in
alleviating PTSD symptoms associated with mild (e.g., loss of a pet) and severe (e.g., witnessing
death of a friend or family member) traumas for military and civilian populations (Cahill,
Rothbaum, Resick, and Folette, 2008). Graca, Palmer and Occhietti (2012) found CPT is an
effective treatment for PTSD in a VA residential setting, based on pre and post scores of three
test different test measures. And Friedman (2005) determined CPT and PE have met the most
rigorous scientific criteria for efficacy.
Eye movement desensitization and reprocessing therapy (EMDR), on the other hand, has
produced mixed results within current research. Lazrove et al. (1998) found that, of seven adult
participants who completed three 90-minute sessions of EMDR, none met criteria for PTSD, as
stated in the Diagnostic and Statistical Manual-III-R (American Psychiatric Association [APA],
1987), two months after treatment. Högberg et al. (2008) also found that 17 participants with
chronic PTSD did not meet criteria, as stated in the Diagnostic and Statistical Manual-IV (APA,
1994), directly after treatment, as well as at 8 and 35 months after treatment.
However, in a study by Lee and Drummond (2008), EMDR, when administered to 48
participants over one session and measured one week later, reduced distress but not vividness
associated with traumatic memories. A lack of strong empirical evidence and theoretical
groundwork in the veteran population (i.e., some scholars believe EMDR is based solely on
imaginal exposure and/or an educational structure) for EMDR are given as the main reasons by
military and veterans’ health agencies for continuing research into its effectiveness as a treatment
for PTSD (Sharpless and Barber, 2011; Institute of Medicine, 2007). Dworkin (2003), in his
case study analysis of EMDR as an effective therapy, did not dismiss it as invalid. Rather, he
suggested that aspects of the therapeutic relationship that develop between the clinician and
client during EMDR, including empathy, transference, and countertransference, are commonly
misunderstood, overlooked, or both, decreasing the benefits the therapy has to offer.
Current literature also suggests many veterans, especially females, present to VA Primary Health
Clinics with physical complaints, which may be the result of or include underlying mental health
issues (Friedman, 2005; Shiner, 2011). Consequently, any symptoms of PTSD or other mental
health disorders veterans may have can go undetected by clinicians.
However, changes within the VA, such as the integration of primary care and mental health
departments, has greatly improved this screening process (Sadler, Booth, Nielson, and
Doebbeling, 2000; Valente and Wight, 2007). Additional studies indicate there are several
factors which may influence veterans’ participation in and completion of PTSD treatment,
including severity of PTSD symptoms, health, family and work commitments, motivation for
change, and family involvement/social support before, during, and after treatment (Kutter, Wolf,
and McKeever, 2004; Batten et al., 2009).
The VA offers several programs for the treatment of PTSD. These services, as with any VA
care, are offered to all veterans who have: a) completed active military service in the Army,
Navy, Air Force, Marines, Coast Guard, or Merchant Marines During World War II or are
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National Guard members or reservists who have completed a federal deployment in a combat
zone and b) been discharged under other than dishonorable conditions (NCPTSD, 2010).
Each program offers evaluation, education, and treatment. The program services include: a) oneto-one mental health assessment and testing, b) medication, c) one-to-one psychotherapy and
family therapy, and d) group therapy, which covers topics such as combat support, anger and
stress, and partner relationships. Additionally, every VA medical center has providers trained to
provide PTSD treatment.
Designated VA medical centers also offer one or both of two unique PTSD treatment programs.
The first is Specialized Outpatient PTSD Programs (SOPPs). Three types of outpatient clinics
comprise SOPPs which allow veterans to meet with a provider on a regular basis: a) PTSD
Clinical Teams (PCTs) provide group and one-to-one treatment, b) Substance Use PTSD Teams
(SUPTs) treat the combined issues of PTSD and substance use, and c) Women’s Stress Disorder
Treatment Teams (WSDTTs) offer women veterans both group and one-to-one treatment.
The other unique PTSD treatment program is called Specialized Intensive PTSD Programs
(SIPPs). Treatment services are carried out in a therapeutic environment. Many of the
individual programs under SIPPs are residential, where veterans live at the VA facility during
treatment. Social, recreational, vocational activities and counseling are part of SIPPs. Programs
include: a) outpatient PTSD Day Hospitals, which provide one-to-one and group treatment for 4
to 8 hours on a daily basis, b) Evaluation and Brief Treatment of PTSD Units (EBTPUs), which
provide PTSD treatment for a short time ranging from 14 to 28 days, c) PTSD Residential
Rehabilitation Programs (PRRPs), which offer PTSD treatment and case management, with the
goal of helping trauma survivors return to a healthy, functional life within their communities;
stays in this program are commonly 28 to 90 days long, d) Specialized Inpatient PTSD Units
(SIPUs), which offer trauma focused treatment within a VA facility for an average length of 28
to 90 days, e) PTSD Domiciliary (PTSD Dom), which provides residential treatment for a
designated time period, with a goal of assisting veterans in improving their mental and physical
health and transitioning to outpatient mental health care, and f) Women’s Trauma Recovery
Program (WTRP), which is a 60-day residential program focused on war zone-related stress and
MST and allows veterans to work on their social skills so they may deal more comfortably with
others (NCPTSD, 2010).
The Saint Cloud VA PTSD residential treatment program was started in 2000 and initially was
limited to providing group trauma exposure for combat veterans, which was the most effective
therapy available at that time. In 2007, this program expanded to include offering CPT in a
format combining group CPT with individual trauma processing. The Saint Cloud VA was one
of the first VA facilities to make this addition. Shortly after making this change, the three
evidenced-based individual trauma processing therapies, PE, CPT, and EMDR, were made
available in the program. Currently, however, only CPT and PE are being offered. All PTSD
program staff members who provide psychotherapy are certified in either CPT or PE, or both.
Since the inception of this program, outcome data has been collected to assess effectiveness,
efficiency, and satisfaction as they relate to the services provided. The outcome data
management system was developed and has been continually modified to conform to the
Commission on Accreditation of Rehabilitation Services (CARF) standards (2008).
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Veterans entering into the Saint Cloud VA PTSD residential program have an established
diagnosis of PTSD. Diagnosis is established after evaluation by a mental health professional.
For the purposes of this project, diagnosis will be confirmed by reviewing the veterans’ problem
lists, psychiatric evaluations and/or psychological evaluations. They enter the 45-day PTSD
program as a cohort group of up to 16 veterans per group. After assessing their needs, they are
assigned to either the group trauma exposure track or the CPT track. All veterans in the group
trauma exposure track have combat-related PTSD and those in the CPT track have PTSD
resulting from combat and/or non-combat.
Veterans in the CPT track are assigned an individual therapist for trauma processing. The
individual therapist provides either CPT or PE. All veterans in the CPT track participate in a 3-4
times weekly CBT group focused on work on their cognitive distortions and negative beliefs.
Veterans in the group trauma exposure track do their trauma processing in a group setting. They
participate in a 4 times weekly trauma processing group. Veterans in both tracks attend PTSD
psychoeducational and skill building groups together (e.g., stress management, seeking safety,
spirituality, and anger management groups).
All veterans who enter the Saint Cloud PTSD program also receive a battery of clinical outcome
measures upon admission into and discharge from the program. These measures include the
Beck Anxiety Inventory, Beck Depression Inventory-II, PTSD Checklist, and Posttraumatic
Growth Inventory. Up until 2009, 6- and 12-month outcome data was also being collected;
approximately 40% of graduates from the program completed measures at one or both follow-up
times. In addition, data is also collected on completion rate and veteran satisfaction with
individual therapies and psychoeducational groups offered.
The knowledge base for the effectiveness of various PTSD treatments offered in VA settings is
still transforming and expanding. In fact, the IOM, at the request of the DOD, is currently
conducting a study of all PTSD treatments offered at VA and DOD facilities to determine the
best method(s) for screening, prevention, treatment, and rehabilitation of active duty military
personnel and veterans with PTSD (Levin, 2011).
A summary of the literature reveals valuable information for the advancement of PTSD
treatment. Even though PE, CPT, and EMDR are currently supported by empirically-based
evidence, future research will help solidify their foundation as sound and effective PTSD
treatments and offer insight into ways in which they can be improved. Additionally, potential
studies that sample the veteran population can help clarify the effectiveness of these therapies
with the VA. This research project was developed for just that purpose. An evaluation of a VA
PTSD residential treatment program is being proposed to answer the following research
question: How does a PTSD program offered through the VA affect symptoms PTSD and
depression in veterans who have completed treatment?
Objective/Hypothesis:
1) Veterans who receive any of the evidence-based individual psychotherapies (i.e., PE,
CPT, or EMDR) will show a reduction in symptoms of PTSD and depression upon
discharge from the program, will show a slight increase in symptoms at 6-month followup and a leveling off of symptom intensity by 12-month follow-up. These findings will
vary by veterans’ demographic characteristics, including age and ethnicity.
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2) There will be no significant differences between PE, CPT, and EMDR in their effect on
veterans’ symptoms of PTSD and depression.
Significance: The most recent literature regarding the best evidence-based therapies for PTSD
forms a consensus that PE, CPT, and EMDR are evidence-based. The VA and DOD have made
a commitment to providing evidence-based psychotherapy for PTSD to our combat veterans.
Another group of veterans that has been identified for targeted psychiatric services are males and
females with PTSD due to military sexual trauma (MST). To fulfill this commitment, the VA’s
well-established network of residential PTSD programs have expanded to provide services to
veterans with non-combat-related and combat-related PTSD and to accommodate female
veterans.
As one of the VA residential PTSD programs that has offered CPT, PE, and EMDR (and
continues to offer CPT and PE), this proposed comparative study will explore the effectiveness
of these therapies on symptoms of PTSD and depression over time (i.e., at pre, post, 6-, and 12month follow-up points of measurement). Thus, the findings, while lacking in methodological
rigor, due to such factors as a non-random sample, will provide valuable information for the
future of the Saint Cloud PTSD program, as well as generalize to other PTSD residential
treatment settings in the VA.
Sample Identification: All veterans who were admitted to the Saint Cloud PTSD residential
program from August, 2006 to September, 2009 and completed pre, post, 6-, and 12-month
follow-up measures are to be included in the sample. Criteria for admission to the program
includes: a) established diagnosis of PTSD, b) sobriety for 45 days prior to admission if the
veteran had a prior substance abuse or dependence diagnosis, c) stability on psychotropic
medications, d) no suicide risk for at least two weeks prior to admission, and e) the veteran has
not completed a PTSD program in the last year.
Data Collection: Outcome data from the Beck Depression Inventory-II and PTSD Checklist
from the Saint Cloud PTSD residential program will be utilized. A chart review will also be
conducted to gather some demographic information (i.e., age and ethnicity) and type of therapy
received on subjects included in the sample.
Statistical Analysis: Data will be collected and stored on an Excel spreadsheet. Data will be
analyzed at the Saint Cloud VA using SPSS software. Analyses of outcomes will include
comparisons of pre- and posttest measures; and follow-ups. ANOVAs, t-tests, and correlations
will be used for continuous variables. Chi-square tests will be used for nominal or categorical
data. Regression analysis will also be used for continuous and/or categorical variables.
Timeline: This project must be completed by May, 2012, in order to satisfy graduation
requirements set forth by the student’s Master of Social Work Program through the University of
Saint Thomas and Saint Catherine’s University.
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